Compare PDSB & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDSB | LFVN |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.0M | 51.5M |
| IPO Year | 2015 | 1996 |
| Metric | PDSB | LFVN |
|---|---|---|
| Price | $1.17 | $9.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $9.00 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 1.1M | 455.8K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | 28.16 | ★ 226.09 |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $203,204,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $27.73 |
| Revenue Growth | N/A | ★ 1.86 |
| 52 Week Low | $0.51 | $3.90 |
| 52 Week High | $1.90 | $15.00 |
| Indicator | PDSB | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 73.31 |
| Support Level | $0.85 | $4.67 |
| Resistance Level | $1.47 | $14.28 |
| Average True Range (ATR) | 0.14 | 1.25 |
| MACD | -0.01 | 0.34 |
| Stochastic Oscillator | 35.86 | 67.71 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.